Terms: = Thyroid cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
22 results:
1. Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma.
Jiang N; Jiao B; Zhang L; Li J; Li Y; Lin C
Ann Med; 2023 Dec; 55(1):2232372. PubMed ID: 37435919
[TBL] [Abstract] [Full Text] [Related]
2. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
3. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
4. Nogo-B promotes invasion and metastasis of nasopharyngeal carcinoma via rhoa-SRF-MRTFA pathway.
Wang J; Zhong Q; Zhang H; Liu S; Li S; Xia T; Xiao Z; Chen R; Ye Y; Liang F; Han P; Huang X
Cell Death Dis; 2022 Jan; 13(1):76. PubMed ID: 35075114
[TBL] [Abstract] [Full Text] [Related]
5. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Lin L; Wen J; Lin B; Chen H; Bhandari A; Qi Y; Zheng D; Wang O
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):481-491. PubMed ID: 33674820
[TBL] [Abstract] [Full Text] [Related]
6. Management of thyroid cancer: results from a German and French patient survey.
Büttner M; Rimmele H; Bartès B; Singer S; Luster M
Hormones (Athens); 2021 Jun; 20(2):323-332. PubMed ID: 33184762
[TBL] [Abstract] [Full Text] [Related]
7. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
Machens A; Lorenz K; Weber F; Dralle H
Eur J Surg Oncol; 2021 Apr; 47(4):920-923. PubMed ID: 32962888
[TBL] [Abstract] [Full Text] [Related]
8. Factors infuencing the sensitivity of ultrasound and gamma location of the parathyroid adenoma.
Acín-Gándara D; Pereira-Pérez F; Medina-García M; Sebastián-Viana Tomás
Cir Esp (Engl Ed); 2020 Jan; 98(1):18-25. PubMed ID: 31640852
[TBL] [Abstract] [Full Text] [Related]
9. treatment of solitary thyroid nodules according to size, preoperative fine-needle aspiration cytology and frozen section: a retrospective single centre study.
Agrafiotis AC; Sokolow Y; Ruiz-Patino M; D'Haene N; Salmon I; Corvilain B; Cappello M
Acta Chir Belg; 2019 Oct; 119(5):294-302. PubMed ID: 30614397
[No Abstract] [Full Text] [Related]
10. A Nonpump Function of Sodium Iodide Symporter in thyroid cancer via Cross-talk with PTEN Signaling.
Feng F; Yehia L; Ni Y; Chang YS; Jhiang SM; Eng C
Cancer Res; 2018 Nov; 78(21):6121-6133. PubMed ID: 30217930
[TBL] [Abstract] [Full Text] [Related]
11. S100A4 Knockout Sensitizes Anaplastic thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
Jiao X; Zhang H; Xu X; Yu Y; Zhang H; Zhang J; Ning L; Hao F; Liu X; Niu M; Chen CT; Chen D; Zhang K
Cell Physiol Biochem; 2018; 49(3):1143-1162. PubMed ID: 30196299
[TBL] [Abstract] [Full Text] [Related]
12. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic thyroid cancer.
Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
[TBL] [Abstract] [Full Text] [Related]
13. Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.
Tahara M; Schlumberger M; Elisei R; Habra MA; Kiyota N; Paschke R; Dutcus CE; Hihara T; McGrath S; Matijevic M; Kadowaki T; Funahashi Y; Sherman SI
Eur J Cancer; 2017 Apr; 75():213-221. PubMed ID: 28237867
[TBL] [Abstract] [Full Text] [Related]
14. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary thyroid cancer.
Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of Prognostic Factors Associated With Differentiated thyroid Carcinoma With Pulmonary Metastasis.
Qutbi M; Shafeie B; Amoui M; Tabeie F; Azizmohammadi Z; Mahmoud-Pashazadeh A; Javadi H; Assadi M; Asli IN
Clin Nucl Med; 2016 Dec; 41(12):917-921. PubMed ID: 27764045
[TBL] [Abstract] [Full Text] [Related]
16. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric papillary thyroid cancer >1 cm: is total thyroidectomy necessary?
Nice T; Pasara S; Goldfarb M; Doski J; Goldin A; Gow KW; Nuchtern JG; Vasudevan SA; Langer M; Beierle EA
J Pediatr Surg; 2015 Jun; 50(6):1009-13. PubMed ID: 25819020
[TBL] [Abstract] [Full Text] [Related]
18. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract] [Full Text] [Related]
19. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and rhoa/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract] [Full Text] [Related]
20. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract] [Full Text] [Related]
[Next]
